Dr. Ali Al-Ghamrawy, Chairman of the EDA, received a high-level delegation from IQVIA, headed by Mr. José Luis Fernández, Senior Vice President and General Manager of Africa, Middle East and Southern Europe, in the presence of Dr. Mohamed Mostafa, Vice President and General Manager of Growth Markets and Strategic Partnerships for the Middle East and Africa; Dr. Mohamed Omar, General Manager for Egypt, Sudan and Libya; and Dr. Mostafa Ghorab, Senior Business Development Consultant for the Government Business and Public Health in Egypt, Sudan and Libya. The meeting aimed to explore joint cooperation and leverage the company’s advanced technological expertise and solutions to support and develop Egypt’s pharmaceutical and regulatory ecosystem.
The meeting addressed several priority areas, primarily supporting digital transformation efforts across the regulatory framework, developing smart regulatory platforms and solutions, and leveraging artificial intelligence applications and advanced data analytics technologies to enhance regulatory and oversight processes and strengthen data-driven decision-making processes.
Both sides also discussed ways to leverage pharmaceutical databases and specialized analytics to monitor and analyze the pharmaceutical market, forecast demand and supply requirements, support strategic planning efforts, enhance market foreseeability, and improve the efficiency of resource management.
Furthermore, discussions touched upon potential collaboration in Real-World Evidence, pharmacovigilance, health data analysis, and treatment outcomes. Such cooperation would support the development of more effective tools for monitoring and analyzing data and leveraging insights to support health policies and enhance the efficiency of the pharmaceutical system.
The two sides also discussed opportunities for cooperation in capacity building, knowledge transfer, the exchange of international expertise, and best practices in regulatory science and health innovation. This would contribute to developing specialized professionals and enhancing performance in line with the latest global trends.
Dr. Al-Ghamrawy emphasized the importance of continuing to leverage the latest technologies, digital solutions, data, and artificial intelligence to enhance regulatory performance. He noted that this is aligned with the Egyptian State’s direction toward digital transformation and fostering innovation, while contributing to strengthening the efficiency of the pharmaceutical system and enhancing its ability to respond to the sector’s evolving requirements and challenges.
For their part, IQVIA representatives commended the EDA's efforts to advance regulatory and pharmaceutical standards. They reiterated the company's commitment to strengthening joint cooperation and utilizing its global expertise in digital transformation, AI, and health data analytics to support data-driven governance, decision-making, and mutual knowledge exchange.
This comes as part of the EDA’s commitment to developing Egypt’s pharmaceutical and regulatory system and strengthening its ability to keep pace with global developments in pharmaceutical regulation, innovation, and healthcare technologies.